Heat Biologics Stock Analysis

HTBX -  USA Stock  

USD 7.20  0.15  2.13%

The current Heat Biologics price slide may raise some interest from investors. The stock closed today at a share price of 7.20 on 412,000 in trading volume. The company executives were unable to exploit market volatilities in May. However, diversifying your overall positions with Heat Biologics can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.16. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Heat Biologics partners.
Please check Risk vs Return Analysis.

Search Stock Analysis 

 
Refresh
The Heat Biologics stock analysis report makes it easy to digest most publicly released information about Heat Biologics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Heat Biologics stock analysis module also helps to analyze the Heat Biologics price relationship with some important fundamental indicators such as market cap and management efficiency.

Heat Biologics Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Heat Biologics recorded a loss per share of 1.37. The entity had not issued any dividends in recent years. The firm had 1-7 split on the 11th of December 2020. Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patients immune system against cancer through T-cell activation and expansion. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina. Heat Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people. To learn more about Heat Biologics call Jeffrey Wolf at 919 240 7133 or check out http://www.heatbio.com.

Heat Biologics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Heat Biologics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Heat Biologics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Heat Biologics generates negative expected return over the last 90 days
Heat Biologics has high historical volatility and very poor performance
Heat Biologics is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 2.58 M. Net Loss for the year was (27.29 M) with loss before overhead, payroll, taxes, and interest of (9.99 M).
Heat Biologics currently holds about 132.06 M in cash with (21.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.23.
Heat Biologics has a frail financial position based on the latest SEC disclosures
Latest headline from www.equities.com: Heat Biologics Inc gains 5.5900 percent for June 07 - Equities.com

Heat Biologics Largest EPS Surprises

Earnings surprises can significantly impact Heat Biologics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2014-11-14
2014-09-30-0.41-0.46-0.0512 
2020-05-15
2020-03-31-0.7-0.77-0.0710 
2015-05-14
2015-03-31-0.49-0.57-0.0816 
View All Earnings Estimates

Heat Biologics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Heat Biologics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Heat Biologics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Heat Biologics specific information freely available to individual and institutional investors to make a timely investment decision.
4th of June 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View
20th of May 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View
5th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
12th of April 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View
25th of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
12th of March 2021
Financial Statements and Exhibits. Material Modifications to Rights of Security Holders. Entry into a Material Definitive Agreement
View
9th of February 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View
27th of January 2021
Financial Statements and Exhibits. Other Events
View

Heat Biologics Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Heat Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Heat Biologics backward and forwards among themselves. Heat Biologics' institutional investor refers to the entity that pools money to purchase Heat Biologics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares979.3 K7.1 M
Blackrock IncCommon Shares481.9 K3.5 M
Geode Capital Management LlcCommon Shares192.1 K1.4 M
Susquehanna International Group LlpPut Options181.1 K1.3 M
Principal Financial Group IncCommon Shares152.3 K1.1 M
Qube Research Technologies LtdCommon Shares125.1 K911 K
Citadel Advisors LlcCall Options90.3 K657 K
Susquehanna International Group LlpCommon Shares89.2 K649 K
Indexiq Advisors LlcCommon Shares58 K422 K
Note, although Heat Biologics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Heat Biologics Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 177.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Heat Biologics's market, we take the total number of its shares issued and multiply it by Heat Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Heat Biologics Profitablity

Heat Biologics' profitability indicators refer to fundamental financial ratios that showcase Heat Biologics' ability to generate income relative to its revenue or operating costs. If, let's say, Heat Biologics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Heat Biologics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Heat Biologics' profitability requires more research than a typical breakdown of Heat Biologics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.30) (0.32) 
Return on Average Equity(0.33) (0.36) 
Return on Invested Capital(0.41) (0.44) 
Return on Sales(8.84) (9.54) 

Management Efficiency

The entity has return on total asset (ROA) of (18.8) % which means that it has lost $18.8 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (33.9) %, meaning that it created substantial loss on money invested by shareholders. Heat Biologics management efficiency ratios could be used to measure how well heat biologics manages its routine affairs as well as how well it operates its assets and liabilities. Return on Average Assets is likely to drop to -0.32 in 2021. Return on Average Equity is likely to drop to -0.36 in 2021. Heat Biologics Total Assets are fairly stable at the moment as compared to the past year. Heat Biologics reported Total Assets of 124.19 Million in 2020. Current Assets is likely to rise to about 122.8 M in 2021, whereas Return on Average Assets are likely to drop (0.32)  in 2021.
Last ReportedProjected for 2021
Book Value per Share 7.27  7.46 
Enterprise Value over EBIT(3.60) (3.69) 
Enterprise Value over EBITDA(3.88) (3.98) 
Price to Book Value 1.05  1.44 
Tangible Assets Book Value per Share 7.68  7.88 
Enterprise Value99.4 M107.2 M
Tangible Asset Value122.7 M132.4 M

Technical Drivers

As of the 19th of June, Heat Biologics retains the market risk adjusted performance of (1.33), and Risk Adjusted Performance of (0.0326). Heat Biologics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed nineteen technical drivers for Heat Biologics, which can be compared to its competitors. Please check out Heat Biologics standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Heat Biologics is priced fairly, providing market reflects its last-minute price of 7.2 per share. Given that Heat Biologics has jensen alpha of (0.22), we strongly advise you to confirm Heat Biologics's regular market performance to make sure the company can sustain itself at a future point.

Heat Biologics Price Movement Analysis

The output start index for this execution was six with a total number of output elements of fifty-five. The Weighted Moving Average calculates a weight for each value in Heat Biologics price series with the more recent values given greater weights. View also all equity analysis or get more info about weighted moving average overlap studies indicator.

Heat Biologics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heat Biologics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heat Biologics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heat Biologics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Heat Biologics Predictive Daily Indicators

Heat Biologics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Heat Biologics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Heat Biologics Forecast Models

Heat Biologics time-series forecasting models is one of many Heat Biologics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Heat Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Heat Biologics Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Heat Biologics stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Heat Biologics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Heat Biologics. By using and applying Heat Biologics Stock analysis, traders can create a robust methodology for identifying Heat Biologics entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(8.69) (9.38) 
Gross Margin 0.90  0.89 
Profit Margin(8.84) (9.54) 
Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patients immune system against cancer through T-cell activation and expansion. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina. Heat Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Current Heat Biologics Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Heat Biologics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Heat Biologics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
23.2Strong Buy5Odds
Heat Biologics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Heat Biologics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Heat Biologics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Heat Biologics, talking to its executives and customers, or listening to Heat Biologics conference calls.
Heat Biologics Analyst Advice Details

Heat Biologics Stock Analysis Indicators

Heat Biologics stock analysis indicators help investors evaluate how Heat Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Heat Biologics shares will generate the highest return on investment. By understating and applying Heat Biologics stock analysis, traders can identify Heat Biologics position entry and exit signals to maximize returns.
Quick Ratio43.39
Fifty Two Week Low4.90
Revenue Growth-40.30%
Average Daily Volume Last 10 Day5.98M
Shares Short Prior Month2.61M
Average Daily Volume In Three Month998.37k
Shares Percent Shares Out9.25%
Forward Price Earnings-5.99
Short Percent Of Float9.68%
Float Shares24.16M
Fifty Two Week High30.10
Fifty Day Average6.67
Enterprise Value To Ebitda-1.71
Two Hundred Day Average7.23
Enterprise Value To Revenue17.85
Please check Risk vs Return Analysis. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Heat Biologics Stock analysis

When running Heat Biologics price analysis, check to measure Heat Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heat Biologics is operating at the current time. Most of Heat Biologics' value examination focuses on studying past and present price action to predict the probability of Heat Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Heat Biologics' price. Additionally, you may evaluate how the addition of Heat Biologics to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
The market value of Heat Biologics is measured differently than its book value, which is the value of Heat Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of Heat Biologics' value that differs from its market value or its book value, called intrinsic value, which is Heat Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heat Biologics' market value can be influenced by many factors that don't directly affect Heat Biologics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heat Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Heat Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heat Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.